Hin Sang Group (International) Holding Co. Ltd., together with its subsidiaries, engages in the manufacture, marketing, and sale of healthcare products for children in Hong Kong and Mainland China. It operates in four segments: Product Development, Brand Development and Management, Trading of Goods, and Healthcare. The Product Development segment develops and sells personal care products, household products, and health supplements under the Hin Sang, Tai Wo Tong, Yabune, Weverse, Care Plus, and King’s Antiseptic brands. Its Brand Development and Management segment engages in marketing, selling and distribution, logistics, and delivery services of personal care products; and manages and develops brands for its brand proprietors. The Trading of Goods segment engages in the trading, distribution, and sale of skin care products, personal care products, and household products purchased from various authorized dealers, independent traders, manufacturers, parallel importers, and suppliers. Its Healthcare segment engages in the provision of Chinese medical healthcare, including medical treatment and consultation by Chinese physicians for mothers and children; and the development of mother and child-related health products, medical centers, and related services. The company is also involved in property and investment holding activities. It serves retailers and distributors, and directly to customers through its retail outlets and online channel. The company was founded in 1996 and is headquartered in Tsim Sha Tsui, Hong Kong. Hin Sang Group (International) Holding Co. Ltd. is a subsidiary of Genwealth Group Holding Company Limited.
Metrics to compare | 6893 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship6893PeersSector | |
---|---|---|---|---|
P/E Ratio | −3.9x | −0.4x | 12.1x | |
PEG Ratio | 0.11 | 0.00 | 0.03 | |
Price/Book | 1.2x | 0.8x | 1.5x | |
Price / LTM Sales | 2.1x | 1.0x | 0.9x | |
Upside (Analyst Target) | - | −1.3% | 18.1% | |
Fair Value Upside | Unlock | 19.1% | 11.1% | Unlock |